VIE

Franklin Street Properties Corp. Announces First Quarter 2024 Results

Retrieved on: 
Tuesday, April 30, 2024

Franklin Street Properties Corp. (the “Company”, “FSP”, “we” or “our”) (NYSE American: FSP), a real estate investment trust (REIT), announced its results for the first quarter ended March 31, 2024.

Key Points: 
  • Franklin Street Properties Corp. (the “Company”, “FSP”, “we” or “our”) (NYSE American: FSP), a real estate investment trust (REIT), announced its results for the first quarter ended March 31, 2024.
  • G&A expenses for the first quarter of 2024 were $0.3 million higher than the first quarter of 2023.
  • Today’s news release, along with other news about Franklin Street Properties Corp., is available on the Internet at www.fspreit.com .
  • A conference call is scheduled for May 1, 2024, at 11:00 a.m. (ET) to discuss the first quarter 2024 results.

Veolia and Milwaukee recognize water reclamation infrastructure as an “Ecofactory”

Retrieved on: 
Tuesday, April 23, 2024

“I am pleased Veolia is building on the work of MMSD as it advances the Ecofactory concept.

Key Points: 
  • “I am pleased Veolia is building on the work of MMSD as it advances the Ecofactory concept.
  • Building on this impressive track record, Veolia and MMSD are exploring new opportunities to enhance Milwaukee's water infrastructure through the Ecofactory approach.
  • The Ecofactory initiative goes beyond technical advancements to recognize how the MMSD and Veolia have engaged deeply with Milwaukee's communities, neighborhoods and needs.
  • The Ecofactory in Milwaukee is set to become a model for sustainable water management and community involvement.

Emmaus Life Sciences Reports Delayed Filing of Annual Report

Retrieved on: 
Monday, April 15, 2024

TORRANCE, Calif., April 15, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported today that the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 will be delayed.

Key Points: 
  • TORRANCE, Calif., April 15, 2024 /PRNewswire/ -- Emmaus Life Sciences, Inc. (OTCQX: EMMA), a commercial-stage biopharmaceutical company and leader in the treatment of sickle cell disease, reported today that the filing of its Annual Report on Form 10-K for the year ended December 31, 2023 will be delayed.
  • "We had hoped to file our Annual Report by today's filing deadline but are still working with our independent registered public accounting firm to complete its review of our accounting for the disposition of our equity interest in a variable interest entity, or VIE, near the end of 2023.
  • We anticipate filing the Form 10-K within the next week or so," explained Willis Lee, Chairman of the Board and Co-president of Emmaus.

Franklin Street Properties Corp. Announces Fourth Quarter and Full Year 2023 Results

Retrieved on: 
Monday, February 26, 2024

Overall, the portfolio weighted average rent per occupied square foot was $30.72 as of December 31, 2023, compared to $30.48 as of December 31, 2022.

Key Points: 
  • Overall, the portfolio weighted average rent per occupied square foot was $30.72 as of December 31, 2023, compared to $30.48 as of December 31, 2022.
  • Supplementary schedules provide property information for the Company’s owned and consolidated properties as of December 31, 2023.
  • Today’s news release, along with other news about Franklin Street Properties Corp., is available on the Internet at www.fspreit.com .
  • A conference call is scheduled for February 27, 2024, at 11:00 a.m. (ET) to discuss the fourth quarter and full year 2023 results.

DocGo Provides Additional Information to Refute Misleading Short Seller “Report”

Retrieved on: 
Tuesday, January 16, 2024

As we previously advised our shareholders, this short seller mischaracterizes and misrepresents facts that are already known to the public, and uses unsubstantiated claims to intentionally present an overall picture of DocGo, our leadership and our business that is deliberately false, misleading and defamatory.

Key Points: 
  • As we previously advised our shareholders, this short seller mischaracterizes and misrepresents facts that are already known to the public, and uses unsubstantiated claims to intentionally present an overall picture of DocGo, our leadership and our business that is deliberately false, misleading and defamatory.
  • DocGo has a robust compliance department that reviews our billing claims for medical necessity and other billing compliance issues.
  • The Company engages independent third-party audit firms to audit our claims, and independent parties to perform compliance effectiveness reviews.
  • The North East Ambulance Trust is not a subsidiary of DocGo - it is a customer of DocGo.

PINTEC ANNOUNCES UNAUDITED FINANCIAL RESULTS FOR THE FIRST HALF OF 2023

Retrieved on: 
Thursday, December 28, 2023

Total revenues decreased by 11.89% to RMB35.09 million (US$4.86 million) for the first half of 2023 from RMB39.82 million for the same period of 2022.

Key Points: 
  • Total revenues decreased by 11.89% to RMB35.09 million (US$4.86 million) for the first half of 2023 from RMB39.82 million for the same period of 2022.
  • The decrease in revenues from installment service fee was mainly due to the decrease in volume of SMEs loans in the first half of 2023.
  • Cost of revenues increased by 59.90% to RMB30.88 million (US$4.27million) for the first half of 2023 from RMB19.31 million for the same period of 2022.
  • We had service cost charge by the related party of RMB0.03 million and nil for the first half of 2022 and 2023, respectively.

Blue Hat Announces Financial Results for the First Half of 2023, Highlighted by 5,657.93% Increase in Revenues to $46.30 million

Retrieved on: 
Friday, December 22, 2023

First Half of 2023 total revenues of US$46.30 million, compared to US$0.80 million in the prior-year period, due to that increased commodity trading.

Key Points: 
  • First Half of 2023 total revenues of US$46.30 million, compared to US$0.80 million in the prior-year period, due to that increased commodity trading.
  • First Half of 2023 gross profit of US$0.08 million, a decreased of 70.87% from US$0.26 million in the prior-year period.
  • First Half of 2023 loss from operations of US$4.07 million, an increase of 69.79% from loss from continuing operations of US$2.40 million in the prior-year period.
  • Net loss from continued operation increased 77.52% to US$4.36 million for the First Half of 2023, from US$2.46 million in the prior-year period.

UpHealth Provides Corporate Update And Issues Financial Results For The Third Quarter Of 2023

Retrieved on: 
Monday, November 20, 2023

DELRAY BEACH, Fla., Nov. 20, 2023 (GLOBE NEWSWIRE) -- UpHealth, Inc. (“we,” “UpHealth,” or the “Company”) (NYSE: UPH), today issued a corporate update in the form of a letter to shareholders on behalf of CEO, Martin Beck, inclusive of financial results for the third quarter ended September 30, 2023.

Key Points: 
  • For the third quarter of 2023, we reported total revenues of $32.7 million, compared to $38.7 million in the third quarter of 2022.
  • Our gross margin expanded to 54% in the third quarter of 2023, up from 44% in the third quarter of 2022.
  • Due to the deconsolidation of UpHealth Holdings, this excludes approximately $35.6 million of cash at UpHealth Holdings as of September 30, 2023.
  • On September 19, 2023, UpHealth Holdings, a subsidiary of UpHealth, filed a voluntary petition under Chapter 11 of the U.S. Bankruptcy Code.

Oriental Culture Holding LTD Announces First Half Year of 2023 Unaudited Financial Results

Retrieved on: 
Friday, November 17, 2023

During the six months ended June 30, 2023 and 2022, total listing value of listed artwork, collectibles and commodities was approximately $4.7 million and $1.5 billion, respectively.

Key Points: 
  • During the six months ended June 30, 2023 and 2022, total listing value of listed artwork, collectibles and commodities was approximately $4.7 million and $1.5 billion, respectively.
  • The decrease was primarily because we provided less consulting and training services to traders for the six months ended June 30, 2023.
  • Our provision for income taxes was nil for the six months ended June 30, 2022 and $8,643 for the six months ended June 30, 2023, respectively.
  • Basic and diluted earnings (loss) per share were $1.34 and $ (0.50) for the six months ended June 30, 2022 and 2023, respectively, a 137.7% decrease.

Jowell Global Ltd. Announces First Half 2023 Unaudited Financial Results

Retrieved on: 
Friday, November 24, 2023

SHANGHAI, Nov. 24, 2023 /PRNewswire/ -- Jowell Global Ltd. ("Jowell" or the "Company") (NASDAQ: JWEL), one of the leading cosmetics, health and nutritional supplements, and household products e-commerce platforms in China, today announced its unaudited financial results for the six months ended June 30, 2023.

Key Points: 
  • Cost of revenues of household products for the first half 2023 increased about 67.0% as compared to the same period of 2022.
  • Fulfillment expenses were $1.9 million in the first half of 2023, an increase of 10.9% from the $1.8 million in the same period of 2022.
  • Fulfillment expenses as a percentage of total revenues were 2.3% in the first half of 2023, up from 1.7% in the first half of 2022.
  • Marketing expenses were $3.3 million in the first half of 2023, a decrease of 46.7% from the $6.2 million in the same period of 2022.